Notably, multivariate analysis of CSS confirmed that HER-3 expression represented a significant prognostic parameter influencing survival of CRC patients and represented a significant and strong risk factor for death in CRC patients developing MM liver metastases. This evidence concerns the gene ERBB3 and Miyoshi myopathy.